Eli Lilly and Company

Novo Nordisk A/S

Dr. Reddy's Laboratories Limited

Sandoz Group AG

Hims & Hers Health, Inc.

The United Laboratories International Holdings Limited

Huadong Medicine Co., Ltd

DexCom, Inc.

Abbott Laboratories

Lupin Limited

The market for weight loss drugs that <a href="https://oninvest.com/article/vse-o-nikh-govoriat-kak-novye-preparaty-izmeniat-nashu-zhizn">revolutionized</a> pharmacoculture in the early 2020s is entering a new phase. This year, Novo Nordisk's patents for semaglutide, the active ingredient in Ozempic, perhaps the most famous drug in this class, will expire in five major countries. This means that generic manufacturers will enter the race, new numerous players who are already preparing to make money by flooding the world with inexpensive analogs.

Substance-for-money exchange: $32 billion semaglutide market enters patent collapse phase

Tesla, Inc.

Amazon.com, Inc.

Planet Labs PBC

Tennant Company

Serve Robotics Inc.

Richtech Robotics Inc.

Alphabet Inc.

Taiwan Semiconductor Manufacturing Company Limited

Leader Harmonious Drive Systems Co., Ltd.

There is one problem with new technologies - they are, in fact, new. Only those who can prove their maturity reach the stock exchange. Based on the results of the turbulent year 2025, I tried to find out which public companies may become beneficiaries of scientific and technological progress in 2026.

What technologies will drive markets in 2026: space, AI, robots and biotechs

Rocket Lab Corporation

The Boeing Company

5N Plus Inc.

One of the hottest technology topics in December was data centers - data centers - in space. Suddenly, just about everyone is talking about it: Nvidia, Google, Amazon, a number of startups, and the ubiquitous Elon Musk. Let's see what makes the idea of orbital data centers so attractive and whether it will be possible to make money on it in 2026.

AI in orbit: why Elon Musk and Sam Altman want to build data centers in space

Artificial intelligence is no longer a game for startups. In early December, it was <a href="https://www.ft.com/content/3254fa30-5bdb-4c30-8560-7cd7ebbefc5f">reported</a> that Anthropic, which created the Claude AI, had started preparing for an IPO. This is the third signal of this kind - in November, the leader of the AI race <a href="https://oninvest.com/article/prosto-normal-naa-kompania-na-1-trln-kak-openai-prokladyvaet-dorogu-na-birzu">OpenAI</a> and the startup <a href="https://oninvest.com/article/ne-na-blago-vsego-celovecestva-kakoj-ii-sozdaet-cohere-konkurent-openai">Cohere</a> indicated their intention to become public companies. It looks like the AI market is gradually maturing into a public offering, which will give retail investors a chance to directly participate in the AI boom, or bubble, which has been simmering for three years. To be prepared, let's take a closer look at Anthropic - this company is making much less media noise than OpenAI, but is steadily gaining momentum, remaining one of the favorites in the AI race.

Money loves silence: How Claude beat ChatGPT in the corporate segment

Tuesday, November 18 saw <a href="https://blog.google/products/gemini/gemini-3/">the</a> long-awaited launch of Gemini 3, Google's new version of AI, which has generated quite a bit of hype and rumors over the past month. Apparently, the rollout is going well and user feedback is mostly positive. That gave a boost to shares of parent company Alphabet, which were already up when it was revealed that they were <a href="https://www.cnbc.com/2025/11/14/warren-buffetts-berkshire-hathaway-reveals-new-position-in-alphabet.html">bought by</a> legendary investor Warren Buffett's Berkshire Hathaway fund in the third quarter. There is an interesting twist in the frenzied AI race: Gemini is clearly challenging the previously undisputed leader ChatGPT from OpenAI.

Okay, boomer: why Google is back in vogue

Vertex Pharmaceuticals Incorporated

Techno-billionaires from Silicon Valley are actively <a href="https://oninvest.com/article/magnaty-kremnievoj-doliny-delaut-stavki-na-omolozenie-mozno-li-na-etom-zarabotat">investing</a> in finding new ways to extend life. However, they are not only concerned about this - in San Francisco, with the support of OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong, a startup called Preventive has been secretly <a href="https://www.wsj.com/tech/biotech/genetically-engineered-babies-tech-billionaires-6779efc8">working</a> <a href="https://www.preventive.bio/blog/announcing-preventive">for</a> six months to create genetically "improved" babies using the latest DNA editing technologies. And he's not the only one. The idea is a noble one - to rid people of genetic diseases, but critics fear both failure and success of this venture.

Human 2.0: where Silicon Valley's attempt to rewrite DNA is headed

NVIDIA Corporation

Advanced Micro Devices, Inc.

Salesforce, Inc.

AI development company Cohere makes headlines far less frequently than its larger peers. According to its <a href="https://fortune.com/2025/09/09/cohere-looks-to-shed-its-underdog-status-with-a-star-ai-hire-new-cfo-and-7-billion-valuation-chasing-roi-over-agi/">cofounder Nick Frosst</a>, that is deliberate: the company does not seek the attention of the general public and focuses instead on “quiet” sales in the corporate segment. However, at the end of October the company <a href="https://www.bloomberg.com/news/articles/2025-10-21/openai-rival-cohere-looking-to-ipo-soon-ceo-gomez-says">announced</a>&nbsp;that it was preparing for an IPO. For investors, that is a reason to take a closer look.

Not for 'all of humanity': Startup Cohere focuses on AI for businesses

Microsoft Corporation

So, it's happened. After a year of discussions, negotiations and even <a href="https://oninvest.com/article/cukerberg-protiv-al-tmana-kak-delo-openai-raskololo-kremnievuu-dolinu">lawsuits</a>, the leading artificial intelligence developer OpenAI has finally restructured and turned into a commercial company. This will allow its CEO Sam Altman to attract new investments and even go public. It may become the <a href="https://www.reuters.com/business/openai-lays-groundwork-juggernaut-ipo-up-1-trillion-valuation-2025-10-29/">largest</a> IPO in modern history.

"Just a normal company" at $1 trillion: How OpenAI is making its way to the stock exchange

Last week there was a <a href="https://aws.amazon.com/ru/message/101925/">failure</a> on Amazon's servers, which had global consequences: it brought down the work of many large sites and companies for some time. The event clearly showed how much the modern world depends on cloud services, usually invisible to the user, that rent computing power and programs over the Internet. But the AI boom is moving us even further in that direction, sparking a veritable <a href="https://oninvest.com/article/cto-kopaet-glava-openai-sem-al-tman-ekonomiceskij-rov-ili-mogilu">fever of</a> building new cloud data centers. Which may not be needed in such large numbers.

Hyperscalers vs. meek: who will win the AI race

Roman Kutuzov

Writes about:

Articles: 29